Results 51 to 60 of about 243,892 (195)

Ulipristal Acetate: A Review in Uterine Fibroids

, 2018
Compliance with Ethical Standards Funding: The preparation of this review was not supported by any external funding. Conflicts of interest: Karly P.
Karly Garnock-Jones (4985351)
core   +1 more source

Pulmonary Leiomyomatosis in a Postmenopausal Patient After Previous Hysterectomy: A Case Report

Case Reports in Obstetrics and Gynecology, Volume 2026, Issue 1, 2026.
Objective Uterine leiomyoma represents one of the most common pathologies affecting women of reproductive age, often presenting with lower abdominal pain and abnormal bleeding. Benign metastasising leiomyomatosis (BML) is a rare tumour originating from uterine leiomyomas, with the lungs being a common extrauterine location.
Ján Varga, Karolina Just, Alexander Ostró, Manvinder Singh   +3 more
wiley   +1 more source

The experience of ulipristal acetate using in patients with uterine leiomyoma

Репродуктивная эндокринология, 2017
In the study of clinical experience of the use of ulipristal acetate (UPA) – a selective modulator of progesterone receptors – in women with symptomatic uterine leiomyoma, 65 women with a clinically significant tumor were treated.
Р. А. Сафонов, И. Н. Сафонова   +1 more
doaj   +1 more source

Treatment of Uterine Fibroid–Related Heavy Menstrual Bleeding: Variations in Clinical Practice at Four Hospitals in the Netherlands

Obstetrics and Gynecology International, Volume 2026, Issue 1, 2026.
Introduction Uterine fibroids are the most common anatomical cause of heavy menstrual bleeding. To which extent clinical practice variation is present in the treatment of fibroid‐related heavy menstrual bleeding at the hospital level remains unclear. The aim of this study was to identify and evaluate the clinical practice variation in the treatment of ...
Elisabeth R. Knorren, Daniëlle P. C. Huijs, Ingrid M. Nijholt, Jeroen R. Dijkstra, F. Paul H. L. J. Dijkhuizen, Jan Willem van der Steeg, Tycho van der Meer, Martijn F. Boomsma, Maarten D. H. Vink, Peggy M. A. J. Geomini, Marlies Y. Bongers, Jaklien C. Leemans, Agnieszka Bień   +12 more
wiley   +1 more source

Uterine fibroid – new possibilities of nosotropic therapy

Гинекология, 2013
In this article are given the results of studies SMRP: ulipristal acetate in the treatment of uterine fibroids, ulipristal acetate (Esmya).
A L Tikhomirov
doaj  

Empowering organ-preserving treatment of uterine fibroids using ulipristal acetate [PDF]

Гинекология, 2016
The choice of treatment of uterine leiomyoma affects different factors: the intensity of the symptoms of fibroids characteristics, age and the need for preservation of the uterus (and fertility).
A L Tikhomirov
doaj  

The epidemiology and pathogenesis of uterine fibroids

International Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1029-1045, December 2025.
Abstract Uterine fibroids, or leiomyomas, are the most common benign tumors of the female reproductive tract, ultimately affecting a majority of women worldwide, primarily during their reproductive years. While their origin appears genetic, manifesting in monoclonal tumors, diverse features and mechanisms contribute to their growth and further ...
Malcolm G. Munro, Svetlana N. Tchaikovski, Ally Murji   +2 more
wiley   +1 more source

The Concise Guide to PHARMACOLOGY 2025/26: Nuclear hormone receptors

British Journal of Pharmacology, Volume 182, Issue S1, Page S242-S258, December 2025.
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander, John A. Cidlowski, Alasdair J. Gibb, Eamonn Kelly, Alistair A. Mathie, Chloe J. Peach, Emma L. Veale, Jane F. Armstrong, Elena Faccenda, Simon D. Harding, Christopher Southan, Jamie A. Davies, Laurel Coons, Peter J. Fuller, Kenneth S. Korach, Donald P. McDonell, Robert Oakley, Sarah Radi, Rachid Safi, Frances Sladek, Morag J. Young   +20 more
wiley   +1 more source

Medical treatment of fibroids: FIGO best practice guidance

International Journal of Gynecology &Obstetrics, Volume 171, Issue 2, Page 507-512, November 2025.
Abstract Even though uterine fibroids are a widespread condition, the range of approved medical treatment options remains limited. In fact, only a few drugs are officially approved for the therapy of fibroids. In both the USA and the European Medicines Agency region, selected gonadotropin‐releasing hormone (GnRH) antagonists have been approved for this
Ivonne Diaz, Mary Ann Lumsden, Magdalena Zeppernick   +2 more
wiley   +1 more source

Choosing a Surgical Access Point for Hysterectomy: A Paradigm Shift Over a 10-Year Span

Frontiers in Medicine, 2020
Background: When choosing a surgical procedure for a hysterectomy, doctors and patients have various options in terms of the multiple surgical access points available.
Florian Ebner, Florian Ebner, Niko de Gregorio, Christiane Lato, Valerie Ohly, Wolfgang Janni, Jennifer Spohrs, Lucia Jerg-Bretzke, Steffen Walter   +8 more
doaj   +1 more source